Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 104 articles:
HTML format
Text format



Single Articles


    July 2017
  1. LASSALETTA A, Zapotocky M, Mistry M, Ramaswamy V, et al
    Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    J Clin Oncol. 2017 Jul 20:JCO2016718726. doi: 10.1200/JCO.2016.71.8726.
    PubMed     Text format     Abstract available


  2. WEN PY, Chang SM, Van den Bent MJ, Vogelbaum MA, et al
    Response Assessment in Neuro-Oncology Clinical Trials.
    J Clin Oncol. 2017;35:2439-2449.
    PubMed     Text format     Abstract available


  3. VAN DEN BENT MJ, Smits M, Kros JM, Chang SM, et al
    Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    J Clin Oncol. 2017;35:2394-2401.
    PubMed     Text format     Abstract available


  4. CAMPIAN J, Gutmann DH
    CNS Tumors in Neurofibromatosis.
    J Clin Oncol. 2017;35:2378-2385.
    PubMed     Text format     Abstract available


  5. MERCHANT TE
    Current Clinical Challenges in Childhood Ependymoma: A Focused Review.
    J Clin Oncol. 2017;35:2364-2369.
    PubMed     Text format     Abstract available


  6. TEEPEN JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol. 2017;35:2288-2298.
    PubMed     Text format     Abstract available


    June 2017
  7. PARADA LF, Dirks PB, Wechsler-Reya RJ
    Brain Tumor Stem Cells Remain in Play.
    J Clin Oncol. 2017 Jun 22:JCO2017739540. doi: 10.1200/JCO.2017.73.9540.
    PubMed     Text format    


  8. MELLINGHOFF IK, Gilbertson RJ
    Brain Tumors: Challenges and Opportunities to Cure.
    J Clin Oncol. 2017 Jun 22:JCO2017742965. doi: 10.1200/JCO.2017.74.2965.
    PubMed     Text format    


  9. RAMASWAMY V, Taylor MD
    Medulloblastoma: From Myth to Molecular.
    J Clin Oncol. 2017 Jun 22:JCO2017727842. doi: 10.1200/JCO.2017.72.7842.
    PubMed     Text format     Abstract available


  10. ALEXANDER BM, Cloughesy TF
    Adult Glioblastoma.
    J Clin Oncol. 2017 Jun 22:JCO2017730119. doi: 10.1200/JCO.2017.73.0119.
    PubMed     Text format     Abstract available


  11. MACK SC, Northcott PA
    Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    J Clin Oncol. 2017 Jun 22:JCO2017729921. doi: 10.1200/JCO.2017.72.9921.
    PubMed     Text format     Abstract available


  12. SAMPSON JH, Maus MV, June CH
    Immunotherapy for Brain Tumors.
    J Clin Oncol. 2017 Jun 22:JCO2017728089. doi: 10.1200/JCO.2017.72.8089.
    PubMed     Text format     Abstract available


  13. BRINDLE KM, Izquierdo-Garcia JL, Lewis DY, Mair RJ, et al
    Brain Tumor Imaging.
    J Clin Oncol. 2017 Jun 22:JCO2017727636. doi: 10.1200/JCO.2017.72.7636.
    PubMed     Text format     Abstract available


  14. STURM D, Pfister SM, Jones DTW
    Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    J Clin Oncol. 2017 Jun 22:JCO2017730242. doi: 10.1200/JCO.2017.73.0242.
    PubMed     Text format     Abstract available


  15. DIAMANDIS P, Aldape KD
    Insights From Molecular Profiling of Adult Glioma.
    J Clin Oncol. 2017 Jun 22:JCO2017739516. doi: 10.1200/JCO.2017.73.9516.
    PubMed     Text format     Abstract available


  16. GROMMES C, DeAngelis LM
    Primary CNS Lymphoma.
    J Clin Oncol. 2017 Jun 22:JCO2017727602. doi: 10.1200/JCO.2017.72.7602.
    PubMed     Text format     Abstract available


    May 2017
  17. WINICK N, Devidas M, Chen S, Maloney K, et al
    Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 May 23:JCO2016714774. doi: 10.1200/JCO.2016.71.4774.
    PubMed     Text format     Abstract available


  18. LIM SM, Kim HR, Lee JS, Lee KH, et al
    Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
    J Clin Oncol. 2017 May 18:JCO2016713701. doi: 10.1200/JCO.2016.71.3701.
    PubMed     Text format     Abstract available


  19. CHALMERS A, Akerley W
    Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naive, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice.
    J Clin Oncol. 2017 May 8:JCO2017727255. doi: 10.1200/JCO.2017.72.7255.
    PubMed     Text format    


  20. KIM DW, Tiseo M, Ahn MJ, Reckamp KL, et al
    Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
    J Clin Oncol. 2017 May 5:JCO2016715904. doi: 10.1200/JCO.2016.71.5904.
    PubMed     Text format     Abstract available


    April 2017
  21. PAGLIARO LC
    Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    J Clin Oncol. 2017;35:1036-1040.
    PubMed     Text format     Abstract available


    March 2017
  22. BOWERS DC, Moskowitz CS, Chou JF, Mazewski CM, et al
    Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
    J Clin Oncol. 2017 Mar 24:JCO2016701896. doi: 10.1200/JCO.2016.70.1896.
    PubMed     Text format     Abstract available


    January 2017
  23. MAGNUSON WJ, Lester-Coll NH, Wu AJ, Yang TJ, et al
    Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    J Clin Oncol. 2017 Jan 23:JCO2016697144. doi: 10.1200/JCO.2016.69.7144.
    PubMed     Text format     Abstract available


  24. ZHOU L, Deng L, Lu Y
    Epidermal Growth Factor Receptor Mutations in Non-Small-Cell Lung Cancer With Brain Metastasis: Can Up-Front Radiation Therapy Be Deferred or Withheld?
    J Clin Oncol. 2017 Jan 23:JCO2016715706. doi: 10.1200/JCO.2016.71.5706.
    PubMed     Text format    


    December 2016
  25. MOLITORIS JK, Edelman MJ, Regine WF, Feigenberg SJ, et al
    Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016 Dec 28:JCO2016697227.
    PubMed     Text format    


  26. CLEMENT SC, Schouten-van Meeteren AY, Boot AM, Claahsen-van der Grinten HL, et al
    Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
    J Clin Oncol. 2016;34:4362-4370.
    PubMed     Text format     Abstract available


  27. CLOUGHESY T, Finocchiaro G, Belda-Iniesta C, Recht L, et al
    Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA M
    J Clin Oncol. 2016 Dec 5:JCO2015647685.
    PubMed     Text format     Abstract available


  28. WARDAK Z, Choy H
    Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016;34:4064-4065.
    PubMed     Text format    


  29. VON BUEREN AO, Kortmann RD, von Hoff K, Friedrich C, et al
    Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
    J Clin Oncol. 2016;34:4151-4160.
    PubMed     Text format     Abstract available


  30. GADGEEL SM, Shaw AT, Govindan R, Gandhi L, et al
    Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016;34:4079-4085.
    PubMed     Text format     Abstract available


    November 2016
  31. SULMAN EP, Ismaila N, Armstrong TS, Tsien C, et al
    Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
    J Clin Oncol. 2016 Nov 28:JCO2016707562.
    PubMed     Text format     Abstract available


  32. CHOI C, Raisanen JM, Ganji SK, Zhang S, et al
    Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.
    J Clin Oncol. 2016;34:4030-4039.
    PubMed     Text format     Abstract available


    August 2016
  33. LASSALETTA A, Scheinemann K, Zelcer SM, Hukin J, et al
    Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
    J Clin Oncol. 2016 Aug 29. pii: JCO681585.
    PubMed     Text format     Abstract available


  34. MOXON-EMRE I, Taylor MD, Bouffet E, Hardy K, et al
    Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
    J Clin Oncol. 2016 Aug 9. pii: JCO669077.
    PubMed     Text format     Abstract available


    July 2016
  35. CRINO L, Ahn MJ, De Marinis F, Groen HJ, et al
    Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.
    J Clin Oncol. 2016 Jul 18. pii: JCO655936.
    PubMed     Text format     Abstract available


  36. SCHMITZ N, Zeynalova S, Nickelsen M, Kansara R, et al
    CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
    J Clin Oncol. 2016 Jul 5. pii: JCO656520.
    PubMed     Text format     Abstract available


    June 2016
  37. FELIX F, Fontenele J
    Valproic Acid May Be Tested in Patients With H3F3A-Mutated High-Grade Gliomas.
    J Clin Oncol. 2016 Jun 13. pii: JCO671073.
    PubMed     Text format    


  38. RUSTHOVEN CG, Doebele RC
    Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016 Jun 13. pii: JCO672410.
    PubMed     Text format     Abstract available


  39. FAY MF, Head R, Sminia P, Dowson N, et al
    Valproate in Adjuvant Glioblastoma Treatment.
    J Clin Oncol. 2016 Jun 13. pii: JCO672162.
    PubMed     Text format    


    April 2016
  40. CHAMBERLAIN MC
    Targetable Lung Cancer Brain Metastases: Improved Outcome.
    J Clin Oncol. 2016 Apr 25. pii: JCO669465.
    PubMed     Text format    


  41. BRINKMAN TM, Krasin MJ, Liu W, Armstrong GT, et al
    Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study.
    J Clin Oncol. 2016;34:1358-67.
    PubMed     Text format     Abstract available


  42. FINAZZI T
    One Week of Radiotherapy for Glioblastoma: A Noninferiority Trial?
    J Clin Oncol. 2016 Apr 11. pii: JCO657783.
    PubMed     Text format    


  43. KIM H, Leiby BE, Shi W
    Too Little, Too Soon: Short-Course Radiotherapy in Elderly Patients With Glioblastoma.
    J Clin Oncol. 2016 Apr 11. pii: JCO663195.
    PubMed     Text format    


  44. CHINOT OL, Taphoorn MJ, Bais C, Bourgon R, et al
    Reply to T.J. Kruser et al.
    J Clin Oncol. 2016;34:1282-3.
    PubMed     Text format    


  45. BASS JK, Hua CH, Huang J, Onar-Thomas A, et al
    Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
    J Clin Oncol. 2016;34:1248-55.
    PubMed     Text format     Abstract available


  46. LEE EQ, Ruland S, LeBoeuf NR, Wen PY, et al
    Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.
    J Clin Oncol. 2016;34:e87-9.
    PubMed     Text format    


    March 2016
  47. GLASS J, Won M, Schultz CJ, Brat D, et al
    Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
    J Clin Oncol. 2016 Mar 28. pii: JCO648634.
    PubMed     Text format     Abstract available


  48. SOLOMON BJ, Cappuzzo F, Felip E, Blackhall FH, et al
    Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.
    J Clin Oncol. 2016 Mar 28. pii: JCO635888.
    PubMed     Text format     Abstract available


  49. GILBERT MR
    Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results.
    J Clin Oncol. 2016 Mar 21. pii: JCO665364.
    PubMed     Text format    


  50. BOUFFET E, Larouche V, Campbell BB, Merico D, et al
    Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
    J Clin Oncol. 2016 Mar 21. pii: JCO666552.
    PubMed     Text format     Abstract available


  51. HERRLINGER U, Schafer N, Steinbach JP, Weyerbrock A, et al
    Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
    J Clin Oncol. 2016 Mar 14. pii: JCO634691.
    PubMed     Text format     Abstract available


  52. KRUSER TJ
    Systemic Therapy in Unresectable Meningioma Before Radiotherapy.
    J Clin Oncol. 2016 Mar 14. pii: JCO665901.
    PubMed     Text format    


  53. CHAMBERLAIN MC
    What Lessons Are Imparted From SWOG S9005 for Recurrent Meningioma?
    J Clin Oncol. 2016 Mar 14. pii: JCO662288.
    PubMed     Text format    


  54. KORFEL A, Schlegel U, Herrlinger U, Dreyling M, et al
    Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.
    J Clin Oncol. 2016 Mar 14. pii: JCO649897.
    PubMed     Text format     Abstract available


  55. BAGATELL R, McHugh K, Naranjo A, Van Ryn C, et al
    Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.
    J Clin Oncol. 2016;34:740-6.
    PubMed     Text format     Abstract available


    February 2016
  56. RADES D, Segedin B, Conde-Moreno AJ, Garcia R, et al
    Radiotherapy With 4 Gy x 5 Versus 3 Gy x 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).
    J Clin Oncol. 2016;34:597-602.
    PubMed     Text format     Abstract available


  57. KRUSER TJ, Mehta MP, Kozak KR
    Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?
    J Clin Oncol. 2016 Feb 16. pii: JCO647883.
    PubMed     Text format    


  58. PIETANZA MC
    Using a Population-Based Analysis to Determine the Management and Treatment of Early-Stage Small-Cell Lung Cancer.
    J Clin Oncol. 2016 Feb 16. pii: JCO656462.
    PubMed     Text format    


  59. FREEDMAN RA, Gelman RS, Wefel JS, Melisko ME, et al
    Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
    J Clin Oncol. 2016 Feb 1. pii: JCO630343.
    PubMed     Text format     Abstract available


    January 2016
  60. SANDS SA
    Proton Beam Radiation Therapy: The Future May Prove Brighter for Pediatric Patients With Brain Tumors.
    J Clin Oncol. 2016 Jan 25. pii: JCO654350.
    PubMed     Text format    


  61. KAHALLEY LS, Ris MD, Grosshans DR, Okcu MF, et al
    Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.
    J Clin Oncol. 2016 Jan 25. pii: JCO621383.
    PubMed     Text format     Abstract available


  62. TAPHOORN MJ
    Reply to M.C. Chamberlain.
    J Clin Oncol. 2016;34:292.
    PubMed     Text format    


  63. BERNSTEIN LJ, Mason WP, Laperriere N, Chung C, et al
    Cognitive rehabilitation for brain tumor survivors: A pilot study.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  64. HAPPOLD C, Gorlia T, Chinot O, Gilbert MR, et al
    Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
    J Clin Oncol. 2016 Jan 19. pii: JCO636563.
    PubMed     Text format     Abstract available


  65. YANG CJ, Chan DY, Speicher PJ, Gulack BC, et al
    Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
    J Clin Oncol. 2016 Jan 19. pii: JCO638171.
    PubMed     Text format     Abstract available


    December 2015
  66. GILLIGAN T
    Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    J Clin Oncol. 2015 Dec 14. pii: JCO640110.
    PubMed     Text format     Abstract available


  67. KLEINBERG LR
    Reply to C.T. Hiley.
    J Clin Oncol. 2015;33:4122-3.
    PubMed     Text format    


    November 2015
  68. CHAMBERLAIN MC
    Similar Trials With Differing Outcomes: Reconciliation in Glioblastoma.
    J Clin Oncol. 2015 Nov 30. pii: JCO641746.
    PubMed     Text format    


  69. SHI W, Dicker AP
    CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene Rearrangement.
    J Clin Oncol. 2015 Nov 30. pii: JCO639682.
    PubMed     Text format    


  70. OU SI, Ahn JS, De Petris L, Govindan R, et al
    Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.
    J Clin Oncol. 2015 Nov 23. pii: JCO639443.
    PubMed     Text format     Abstract available


  71. EATON RUSSELL CJ, Bouffet E
    Reply to L. Wiener et al.
    J Clin Oncol. 2015;33:3975.
    PubMed     Text format    


  72. WIENER L, Feudtner C, Hinds P, Wolfe J, et al
    Deeper Conversations Need Not Wait Until the End.
    J Clin Oncol. 2015;33:3974.
    PubMed     Text format    


  73. JI Y, Rankin C, Grunberg S, Sherrod AE, et al
    Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
    J Clin Oncol. 2015 Nov 2. pii: JCO.2015.61.6490.
    PubMed     Text format     Abstract available


  74. TURCOTTE LM, Whitton JA, Friedman DL, Hammond S, et al
    Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    J Clin Oncol. 2015;33:3568-75.
    PubMed     Text format     Abstract available


    October 2015
  75. KNISELY JP
    One and Done: A Week of Radiotherapy for Glioblastoma.
    J Clin Oncol. 2015 Oct 26. pii: JCO.2015.64.0763.
    PubMed     Text format    


  76. FELDMAN DR, Lorch A, Kramar A, Albany C, et al
    Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options-An Analysis From the Global Germ Cell Cancer Group.
    J Clin Oncol. 2015 Oct 12. pii: JCO.2015.62.7000.
    PubMed     Text format     Abstract available


  77. JOHUNG KL, Yeh N, Desai NB, Williams TM, et al
    Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
    J Clin Oncol. 2015 Oct 5. pii: JCO.2015.62.0138.
    PubMed     Text format     Abstract available


  78. GOUNDER MM, Nayak L, Sahebjam S, Muzikansky A, et al
    Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.
    J Clin Oncol. 2015;33:3186-92.
    PubMed     Text format     Abstract available


    September 2015
  79. ROA W, Kepka L, Kumar N, Sinaika V, et al
    International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.
    J Clin Oncol. 2015 Sep 21. pii: JCO.2015.62.6606.
    PubMed     Text format     Abstract available


  80. HILEY CT
    Cognitive Impairment in Survivors of Irradiated Brain Tumors Is Multifactorial: Implications of Polypharmacy With Antiepileptics?
    J Clin Oncol. 2015 Sep 14. pii: JCO.2015.62.5350.
    PubMed     Text format    


    August 2015
  81. GAJJAR A, Bowers DC, Karajannis MA, Leary S, et al
    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    J Clin Oncol. 2015 Aug 24. pii: JCO.2014.59.9217.
    PubMed     Text format     Abstract available


  82. LIN X, DeAngelis LM
    Treatment of Brain Metastases.
    J Clin Oncol. 2015 Aug 17. pii: JCO.2015.60.9503.
    PubMed     Text format     Abstract available


  83. SCHMITZ N, Wu HS
    Advances in the Treatment of Secondary CNS Lymphoma.
    J Clin Oncol. 2015 Aug 17. pii: JCO.2015.63.1143.
    PubMed     Text format    


  84. FERRERI AJ, Donadoni G, Cabras MG, Patti C, et al
    High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
    J Clin Oncol. 2015 Aug 17. pii: JCO.2015.61.1236.
    PubMed     Text format     Abstract available


  85. GOLDMAN S, Bouffet E, Fisher PG, Allen JC, et al
    Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
    J Clin Oncol. 2015;33:2464-71.
    PubMed     Text format     Abstract available


    July 2015
  86. RANSOHOFF KJ, Sarin KY, Tang JY
    Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma.
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.62.2225.
    PubMed     Text format    


  87. MAYER TM
    Can We Predict Bevacizumab Responders in Patients With Glioblastoma?
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.62.3637.
    PubMed     Text format    


  88. MORK ME, You YN, Ying J, Bannon SA, et al
    High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.61.4503.
    PubMed     Text format     Abstract available


  89. ROBINSON GW, Orr BA, Wu G, Gururangan S, et al
    Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
    J Clin Oncol. 2015 Jul 13. pii: JCO.2014.60.1591.
    PubMed     Text format     Abstract available


    June 2015
  90. SANDMANN T, Bourgon R, Garcia J, Li C, et al
    Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.
    J Clin Oncol. 2015 Jun 29. pii: JCO.2015.61.5005.
    PubMed     Text format     Abstract available


  91. KOTECHA R, Suh JH
    Reply to M.C. Chamberlain.
    J Clin Oncol. 2015;33:1986-7.
    PubMed     Text format    


  92. GONDI V, Tome WA, Mehta MP
    Reply to M.C. Chamberlain.
    J Clin Oncol. 2015;33:1986.
    PubMed     Text format    


  93. WOLFE J, Orellana L, Ullrich C, Cook EF, et al
    Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study.
    J Clin Oncol. 2015;33:1928-35.
    PubMed     Text format     Abstract available


    May 2015
  94. TAPHOORN MJ, Henriksson R, Bottomley A, Cloughesy T, et al
    Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
    J Clin Oncol. 2015 May 26. pii: JCO.2014.60.3217.
    PubMed     Text format     Abstract available


  95. KOVIC B, Xie F
    Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
    J Clin Oncol. 2015 May 26. pii: JCO.2014.59.7245.
    PubMed     Text format     Abstract available


  96. SUBBIAH IM, Lei X, Weinberg JS, Sulman EP, et al
    Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
    J Clin Oncol. 2015 May 18. pii: JCO.2014.58.8517.
    PubMed     Text format     Abstract available


  97. GIBNEY GT, Atkins MB
    Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
    J Clin Oncol. 2015 May 11. pii: JCO.2014.60.1807.
    PubMed     Text format    


    April 2015
  98. RUSSELL CE, Bouffet E
    Profound answers to simple questions.
    J Clin Oncol. 2015;33:1294-6.
    PubMed     Text format    


    October 2014
  99. SMYTH MJ, Yagita H, McArthur GA
    Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma.
    J Clin Oncol. 2014 Oct 13. pii: JCO.2013.51.3572.
    PubMed     Text format    


    September 2014
  100. ROZATI S, Kempf W, Ostheeren-Michaelis S, Bode-Lesniewska B, et al
    Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS.
    J Clin Oncol. 2014 Sep 29. pii: JCO.2013.51.6559.
    PubMed     Text format    


    April 2014
  101. VAN DEN BROM RR, Makelburg AB, Schroder CP, de Vries EG, et al
    Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
    J Clin Oncol. 2014.
    PubMed     Text format    


  102. WILGENHOF S, Neyns B
    Complete Cytologic Remission of V600E BRAF-Mutant Melanoma-Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib.
    J Clin Oncol. 2014.
    PubMed     Text format    


    March 2014
  103. SAKURAI H, Sugimoto KJ, Shimada A, Imai H, et al
    Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature.
    J Clin Oncol. 2014.
    PubMed     Text format    


  104. HSIEH YY, Yang ST, Li WH, Hu CJ, et al
    Primary Leptomeningeal Melanoma Mimicking Meningitis: A Case Report and Literature Review.
    J Clin Oncol. 2014.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: